Scarica l'app Stockscreener
13.07
2.83%
-0.38
Dopo l'orario di chiusura:
13.20
0.13
+0.99%
Replimune Group Inc Borsa (REPL) Ultime notizie
Replimune launches melanoma therapy in US market By Investing.com - Investing.com Canada
Replimune Announces TUDRIQEV™ Now Available in the U.S. for Advanced Melanoma - Yahoo! Finance Canada
Bronstein, Gewirtz & Grossman LLC Urges Replimune Group, - GlobeNewswire
Replimune CEO and CFO sued for allegedly mislea... - Pluang
SueWallSt Reminds Replimune Group, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of October 5, 2026REPL - TradingView
REPL Stock On Track To Hit All-Time Lows – Here’s Why This Analyst Slashed Price Target By 85% - Stocktwits
Levi & Korsinsky Notifies Replimune Group, Inc. (REPL) InvestorsLead Plaintiff Deadline on October 5, 2026 - ACCESS Newswire
REPL Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Replimune Group, Inc. Securities LawsuitContact Levi & Korsinsky - PR Newswire
REPLIMUNE CLASS ACTION DEADLINE MONDAY: Bragar Eagel & - GlobeNewswire
Preferred dividends of Replimune Group, Inc. – HAN:7R8 - TradingView
DEADLINE ALERT for REPL, DVLT, and UWMC: The Law Offices of - GlobeNewswire
Portnoy Law Firm Announces Class Action on Behalf of Replimune Group, Inc. Investors - GlobeNewswire
REPL Investor Alert: Replimune Group, Inc. Securities Class Action NoticeContact Levi & Korsinsky - GlobeNewswire
Understanding the Setup: (REPL) and Scalable Risk - Stock Traders Daily
Replimune’s Melanoma FDA Decision Pending: This Analyst Sees 40% Upside, ‘High Conviction’ For Approval - Stocktwits
Why Is REPL Stock Soaring 127% After Hours Today? - Stocktwits
Lost Money on Replimune Group, Inc. (REPL)? Contact Levi & Korsinsky to Join Class Action Before October 5, 2026 - ACCESS Newswire
REPL STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Replimune Group, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Securities Lawsuit Alert: Replimune Group, Inc. (REPL)Contact Levi & Korsinsky Before October 5, 2026 - ACCESS Newswire
REPL INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announc - The National Law Review
Class Action Filed Against Replimune Group, Inc. (REPL) Over Securities ViolationsContact Levi & Korsinsky Today - ACCESS Newswire
Class action lawsuit filed against Replimune af... - Pluang
ETFs Investing in Replimune Group, Inc. Stocks - TradingView
Securities Class Action Lawsuit Filed Against Replimune Group, Inc. (REPL)Levi & Korsinsky Represents Shareholders - ACCESS Newswire
Replimune Group, Inc. (REPL) LawsuitInvestors Urged to Contact Levi & Korsinsky Before October 5, 2026 - ACCESS Newswire
Howard G. Smith joins probe into Replimune fraud after FDA BLA rejection - scanx.trade
Investor Alert: Deadline Approaching to Join Replimune Group, Inc. (REPL) Class ActionContact Levi & Korsinsky - ACCESS Newswire
Lost Money on Replimune Group, Inc. (REPL)? Join Class Action Before October 5, 2026Contact Levi & Korsinsky - ACCESS Newswire
REPL Stock Clocks Worst Day In Over 3 Months — New FDA Documents Leave Wall Street Awaiting Another Rejection For Cancer Drug - Stocktwits
Replimune faces securities lawsuit over alleged misleading FDA trial data claims on RP1 drug resubmission. - Pluang
REPL Deadline Alert: SueWallSt Reminds Replimune Group, Inc. (REPL) Investors of Securities Class Action Deadline on October 5, 2026 - PR Newswire
Replimune stock falls 3.79 percent as losses persist - AD HOC NEWS
Investors Urged to Contact Levi & Korsinsky For Information Before October 5, 2026Replimune Group, Inc. (REPL) - ACCESS Newswire
Replimune Group, Inc. (REPL) Class Action Lawsuit: Levi & Korsinsky Reminds Investors of October 5, 2026 Deadline - ACCESS Newswire
REPL UPCOMING DEADLINE: Levi & Korsinsky Alerts Replimune Group, Inc. Stockholders of Securities Class ActionContact the Firm - PR Newswire
Replimune stock gains as share authorization doubles - AD HOC NEWS
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Replimune Group, Inc. of Class Action Lawsuit and Upcoming Deadlines – REPL - FinancialContent
REPL Shareholders Have Opportunity to Lead Replimune Group, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - ACCESS Newswire
Levi & Korsinsky Notifies Replimune Group, Inc. (REPL) Shareholders of Class Action Lawsuit and October 5, 2026 Deadline - ACCESS Newswire
REPL SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Replimune Group, Inc. Stockholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
REPL Investors Have Opportunity to Lead Replimune Group, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - ACCESS Newswire
Replimune Group Inc (NASDAQ: REPL) Share Price, REPL Stock News, REPL Share Price & Updates - kalkine.com.au
Replimune Group, Inc. (REPL) Stock Analysis: A Potential 51.52% Upside In Biotech Innovations - DirectorsTalk Interviews
Did You Lose Money on Replimune Group, Inc. (REPL)? Levi & Korsinsky Urges Investors to Act Before October 5, 2026 - ACCESS Newswire
REPL INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Replimune Group, Inc. Stockholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Replimune shares plunge 84% after FDA rejects R... - Pluang
REPL Shareholder Alert: Replimune Group, Inc. Securities Class Action LawsuitInvestors With Losses May Contact SueWallSt - PR Newswire
REPL INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Replimune Group, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 5, 2026 in Replimune Group, Inc. LawsuitREPL - Morningstar
Class Action Lawsuit Alert: Levi & Korsinsky Reminds Replimune Group, Inc. (REPL) Investors of October 5, 2026 Deadline - ACCESS Newswire
REPL Shareholder Alert: Investors With Losses May Seek to - GlobeNewswire
Levi & Korsinsky Urges Replimune Group, Inc. (REPL) Shareholders to Act Before Lead Plaintiff Deadline October 5, 2026 - ACCESS Newswire
REPL LAWSUIT ALERT: Levi & Korsinsky Notifies Replimune Group, Inc. Investors – Lead Plaintiff Deadline October 5, 2026 - ACCESS Newswire
REPL INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Replimune Group, Inc. Investors Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
REPL Stock Tracks Best Day Ever: This Analyst Sees Higher Approval Odds For Replimune’s Melanoma After ‘Overwhelmingly Positive’ Panel Outcome - Stocktwits
REPL Stock Lost 19% Of Its Value Today – Why Did The FDA Refuse Approval For Its Experimental Melanoma Drug? - Stocktwits
REPL Stock DropRobbins LLP Reminds Investors They May Be - GlobeNewswire
Bragar Eagel & Squire, P.C. Announces that a Class Action - GlobeNewswire
REPL Shareholder Alert: October 5, 2026 Lead Plaintiff Deadline in Replimune Group, Inc. Securities Class ActionContact Levi & Korsinsky - Business Wire
REPL SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Replimune Group, Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
REPL: TUDRIQEV launch targets rapid adoption in key accounts, with expansion and new indications ahead - TradingView
Replimune faces class action over alleged nondi... - Pluang
Replimune at cantor healthcare conference: careful launch, broad pipeline By Investing.com - Investing.com Canada
0.05%
0.82%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):